{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:48:47Z","timestamp":1768034927587,"version":"3.49.0"},"reference-count":44,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2025,1,30]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sarcoidosis is a systemic inflammatory immune disease characterised by noncaseating granulomas. Its course can vary from benign to very severe, requiring appropriate treatment. Few biomarkers are available to monitor the management of these patients and to identify those at risk of poor prognosis. Given the systemic nature of sarcoidosis, we hypothesised that the analysis of urine metabolites could provide valuable biomarkers for the management of severe disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a comparative analysis of urine metabolomics in a consecutive cohort of 37 well-phenotyped patients, using\n                      <jats:sup>1<\/jats:sup>\n                      H nuclear magnetic resonance (NMR) with multivariate statistical analysis, followed by metabolite identification. After NMR spectra acquisition, we used principal component analysis and partial least squares (PLS) discriminant analysis to generate predictive models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A urinary metabolomic signature predictive of severe pulmonary sarcoidosis was identified using a PLS model. We selected five metabolites with significant changes in samples from severe sarcoidosis defined by a composite physiologic index &gt;40 compared to those from nonsevere sarcoidosis. These changes correspond to the decreased levels of taurine, hippurate, serine and creatinine and increased levels of 3-hydroxyisovalerate. This metabolite profile suggests an association with activated inflammatory pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study shows that urinary NMR metabolites can discriminate samples between nonsevere and severe sarcoidosis. It suggests that urinary metabolomic studies in sarcoidosis may be particularly useful to identify potentially relevant biomarkers. However, further validation in a larger cohort of patients at different disease stages is warranted to confirm the relevance of these NMR biomarkers for follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.00763-2024","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T12:50:16Z","timestamp":1741870216000},"page":"00763-2024","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["<sup>1<\/sup>\n                    H-NMR urine metabolomic fingerprint for severity discrimination in pulmonary sarcoidosis"],"prefix":"10.1183","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4070-5569","authenticated-orcid":false,"given":"Florence","family":"Jeny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Nawfal","family":"Triba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Chauveau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilario","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Francois","family":"Bernaudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1451-2376","authenticated-orcid":false,"given":"Philippe","family":"Savarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"2025102509100749000_11.4.00763-2024.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0251ST"},{"key":"2025102509100749000_11.4.00763-2024.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60680-7"},{"key":"2025102509100749000_11.4.00763-2024.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04079-2020"},{"key":"2025102509100749000_11.4.00763-2024.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5261.1165"},{"key":"2025102509100749000_11.4.00763-2024.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.07.008"},{"key":"2025102509100749000_11.4.00763-2024.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.105997"},{"key":"2025102509100749000_11.4.00763-2024.7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case\u2013cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2025102509100749000_11.4.00763-2024.8","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger","year":"2020","journal-title":"Front Immunol"},{"key":"2025102509100749000_11.4.00763-2024.9","doi-asserted-by":"crossref","first-page":"C1336","DOI":"10.1152\/ajpcell.00316.2023","article-title":"The role of the host-microbiome and metabolomics in sarcoidosis","volume":"325","author":"Kim","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"key":"2025102509100749000_11.4.00763-2024.10","first-page":"10","article-title":"Nuclear magnetic resonance spectroscopic analysis of salivary metabolome in sarcoidosis","volume":"33","author":"Duchemann","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025102509100749000_11.4.00763-2024.11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41585-019-0185-3","article-title":"Cancer metabolomic markers in urine: evidence, techniques and recommendations","volume":"16","author":"Dinges","year":"2019","journal-title":"Nat Rev Urol"},{"key":"2025102509100749000_11.4.00763-2024.12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/metabo13090987","article-title":"Metabolite alterations in autoimmune diseases: a systematic review of metabolomics studies","volume":"13","author":"Mujalli","year":"2023","journal-title":"Metabolites"},{"key":"2025102509100749000_11.4.00763-2024.13","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1038\/s41598-022-08388-6","article-title":"Urine autotaxin levels reflect the disease activity of sarcoidosis","volume":"12","author":"Murakami","year":"2022","journal-title":"Sci Rep"},{"key":"2025102509100749000_11.4.00763-2024.14","doi-asserted-by":"crossref","first-page":"19584","DOI":"10.1038\/s41598-019-56174-8","article-title":"Metabolomic and metallomic profile differences between veterans and civilians with pulmonary sarcoidosis","volume":"9","author":"Banoei","year":"2019","journal-title":"Sci Rep"},{"key":"2025102509100749000_11.4.00763-2024.15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11306-015-0932-2","article-title":"Metabolomics connects aberrant bioenergetic, transmethylation, and gut microbiota in sarcoidosis","volume":"12","author":"Geamanu","year":"2016","journal-title":"Metabolomics"},{"key":"2025102509100749000_11.4.00763-2024.16","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-023-02052-4"},{"key":"2025102509100749000_11.4.00763-2024.17","first-page":"29","article-title":"Plasma metabolomic profile in fibrosing pulmonary sarcoidosis","volume":"33","author":"Mirsaeidi","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025102509100749000_11.4.00763-2024.18","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.3390\/jcm9123955","article-title":"Serum metabolomic profiling of patients with non-infectious uveitis","volume":"9","author":"Shimizu","year":"2020","journal-title":"J Clin Med"},{"key":"2025102509100749000_11.4.00763-2024.19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12916-016-0681-8","article-title":"Urine metabolome profiling of immune-mediated inflammatory diseases","volume":"14","author":"Alonso","year":"2016","journal-title":"BMC Med"},{"key":"2025102509100749000_11.4.00763-2024.20","doi-asserted-by":"crossref","first-page":"e0021222","DOI":"10.1128\/spectrum.00212-22","article-title":"The bladder microbiome, metabolome, cytokines, and phenotypes in patients with systemic lupus erythematosus","volume":"10","author":"Liu","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2025102509100749000_11.4.00763-2024.21","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i1.163"},{"key":"2025102509100749000_11.4.00763-2024.22","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"2025102509100749000_11.4.00763-2024.23","doi-asserted-by":"publisher","DOI":"10.1021\/ac051632c"},{"key":"2025102509100749000_11.4.00763-2024.24","doi-asserted-by":"publisher","DOI":"10.1002\/cem.695"},{"key":"2025102509100749000_11.4.00763-2024.25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183228"},{"key":"2025102509100749000_11.4.00763-2024.26","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3390\/metabo12080744","article-title":"1H NMR urinary metabolomic analysis in older adults after hip fracture surgery may provide valuable information for patient profiling \u2013 a preliminary investigation","volume":"12","author":"Douzi","year":"2022","journal-title":"Metabolites"},{"key":"2025102509100749000_11.4.00763-2024.27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3390\/metabo12100963","article-title":"Systematic review of NMR-based metabolomics practices in human disease research","volume":"12","author":"Huang","year":"2022","journal-title":"Metabolites"},{"key":"2025102509100749000_11.4.00763-2024.28","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-014-0764-5)"},{"key":"2025102509100749000_11.4.00763-2024.29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2111053"},{"key":"2025102509100749000_11.4.00763-2024.30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41430-021-01010-4","article-title":"Profiling inflammatory and oxidative stress biomarkers following taurine supplementation: a systematic review and dose-response meta-analysis of controlled trials","volume":"76","author":"Faghfouri","year":"2022","journal-title":"Eur J Clin Nutr"},{"key":"2025102509100749000_11.4.00763-2024.31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/metabo13101061","article-title":"A new biomarker profiling strategy for gut microbiome research: valid association of metabolites to metabolism of microbiota detected by non-targeted metabolomics in human urine","volume":"13","author":"Zheng","year":"2023","journal-title":"Metabolites"},{"key":"2025102509100749000_11.4.00763-2024.32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12985-024-02285-2","article-title":"Metabolic alterations in urine among the patients with severe fever with thrombocytopenia syndrome","volume":"21","author":"Zhang","year":"2024","journal-title":"Virol J"},{"key":"2025102509100749000_11.4.00763-2024.33","doi-asserted-by":"publisher","DOI":"10.1021\/pr500161w"},{"key":"2025102509100749000_11.4.00763-2024.34","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2010.44"},{"key":"2025102509100749000_11.4.00763-2024.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2023.03.001"},{"key":"2025102509100749000_11.4.00763-2024.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2024.01.021"},{"key":"2025102509100749000_11.4.00763-2024.37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/metabo11040245","article-title":"Urinary metabolites enable differential diagnosis and therapeutic monitoring of pediatric inflammatory bowel disease","volume":"11","author":"Yamamoto","year":"2021","journal-title":"Metabolites"},{"key":"2025102509100749000_11.4.00763-2024.38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01866"},{"key":"2025102509100749000_11.4.00763-2024.39","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S2665-9913(23)00302-8","article-title":"Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial","volume":"6","author":"Redl","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"2025102509100749000_11.4.00763-2024.40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111949"},{"key":"2025102509100749000_11.4.00763-2024.41","first-page":"289","article-title":"Body composition profiling in a Dutch sarcoidosis population","volume":"30","author":"Cremers","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025102509100749000_11.4.00763-2024.42","doi-asserted-by":"crossref","first-page":"1253913","DOI":"10.3389\/fimmu.2023.1253913","article-title":"A serum metabolic biomarker panel for early rheumatoid arthritis","volume":"14","author":"Rodr\u00edguez-Muguruza","year":"2023","journal-title":"Front Immunol"},{"key":"2025102509100749000_11.4.00763-2024.43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.689966"},{"key":"2025102509100749000_11.4.00763-2024.44","doi-asserted-by":"publisher","DOI":"10.1348\/1359107041557048"}],"updated-by":[{"DOI":"10.1183\/23120541.50763-2024","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000}}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00763-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:10:16Z","timestamp":1761408616000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00763-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,26]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1183\/23120541.00763-2024"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00763-2024","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}